首页 › 基金 › Eversept Partners, LP › HCA
Eversept Partners, LP 对 HCA 的持仓历史
HCA Healthcare Inc · 医疗保健
Eversept Partners, LP 在 Q2 2026 的 13F 申报中披露持有 HCA(HCA Healthcare Inc)98,252 股,市值约 US$38.3M,约占其申报组合的 2.00%,在其申报持仓中市值排名第 14 位。 Eversept Partners, LP 最近 12 个申报季度中有 12 个季度披露了 HCA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Eversept Partners, LP 对 HCA 的持仓演变
Eversept Partners, LP 于 Q3 2023 首次披露 HCA 持仓:110,073 股(约 US$27.1M)。 该持仓在 Q4 2024 达到峰值 175,808 股,市值约 US$52.8M。 在 12 次申报中,Eversept Partners, LP 5 次增持、6 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 98,252 股、市值约 US$38.3M,环比增持 19,023 股。。 持仓曾出现大幅变动:Q2 2024 增持约 30% (随后一个季度股价上涨 26%)、Q4 2024 增持约 36% (随后一个季度股价上涨 15%)、Q2 2025 减持约 34% (随后一个季度股价上涨 12%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 110.07K | $27.08M | 新进 |
| Q4 2023 | 114.81K | $31.08M | 增持 |
| Q1 2024 | 103.82K | $34.63M | 减持 |
| Q2 2024 | 135.48K | $43.53M | 增持 |
| Q3 2024 | 129.08K | $52.46M | 减持 |
| Q4 2024 | 175.81K | $52.77M | 增持 |
| Q1 2025 | 152.50K | $52.70M | 减持 |
| Q2 2025 | 99.98K | $38.30M | 减持 |
| Q3 2025 | 111.70K | $47.61M | 增持 |
| Q4 2025 | 95.87K | $44.76M | 减持 |
| Q1 2026 | 79.23K | $37.49M | 减持 |
| Q2 2026 | 98.25K | $38.31M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 HCA 与 13F 数据
HCA(HCA Healthcare Inc)属于医疗保健行业。我们追踪的基金中还有 24 只申报持有 HCA,申报仓位最大的包括:Sanders Capital, LLC (US$3.44B), First Eagle 投资管理 (US$1.28B), Arrowstreet 资本 (US$861.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 HCA 的基金
- Sanders Capital, LLC 8.83M 股 · $3.44B · Q2 2026
- First Eagle 投资管理 3.30M 股 · $1.28B · Q2 2026
- Arrowstreet 资本 2.21M 股 · $861.46M · Q2 2026
- NORDEA INVESTMENT MANAGEMENT AB 1.43M 股 · $553.70M · Q2 2026
- Crake Asset Management LLP 1.15M 股 · $449.07M · Q2 2026
更多关于 Eversept Partners, LP
常见问题
How long has Eversept Partners, LP held HCA?
Eversept Partners, LP has disclosed HCA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Eversept Partners, LP's current position in HCA?
As of Q2 2026, Eversept Partners, LP holds 98.25K shares of HCA (HCA Healthcare Inc), valued at $38.31M, representing 2.00% of its reported portfolio and ranking #14.
Has Eversept Partners, LP been buying or selling HCA?
In the latest 13F filing (Q2 2026), Eversept Partners, LP increased its position in HCA. The position peaked in Q4 2024 at 175.81K shares.
Which other funds hold HCA?
Other major institutional holders of HCA include Sanders Capital, LLC, First Eagle 投资管理, Arrowstreet 资本, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.